ClinicalTrials.gov
ClinicalTrials.gov Menu

Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00135993
Recruitment Status : Completed
First Posted : August 26, 2005
Last Update Posted : September 25, 2014
Sponsor:
Information provided by:
UCB Pharma